Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000265326 | SCV000412632 | uncertain significance | Multiminicore myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000304062 | SCV000412633 | uncertain significance | Malignant hyperthermia of anesthesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000361218 | SCV000412634 | uncertain significance | Central core myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000268916 | SCV000412635 | uncertain significance | Neuromuscular disease, congenital, with uniform type 1 fiber | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087825 | SCV000660083 | likely benign | RYR1-related disorder | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000721733 | SCV000852862 | likely benign | not provided | 2018-02-13 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000721733 | SCV003799519 | likely benign | not provided | 2022-05-03 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000721733 | SCV003813144 | uncertain significance | not provided | 2019-05-09 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995873 | SCV004823212 | likely benign | Malignant hyperthermia, susceptibility to, 1 | 2024-02-05 | criteria provided, single submitter | clinical testing |